Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy
Jianbing Du, Zhuo Wan, Cong Wang, et al.
Theranostics (2021) Vol. 11, Iss. 17, pp. 8185-8196
Open Access | Times Cited: 171

Showing 1-25 of 171 citing articles:

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 457
Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring
Wen Li, Ji‐Bin Liu, Likun Hou, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 268
Engineered exosomes from different sources for cancer-targeted therapy
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 193
Current Strategies for Exosome Cargo Loading and Targeting Delivery
Haifeng Zeng, Shaoshen Guo, Xuancheng Ren, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1416-1416
Open Access | Times Cited: 143
Extracellular vesicles: a rising star for therapeutics and drug delivery
Shuang Du, Yucheng Guan, Aihua Xie, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 95
Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle
Tuying Yong, Zhaohan Wei, Lu Gan, et al.
Advanced Materials (2022) Vol. 34, Iss. 52
Closed Access | Times Cited: 81
Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications
Jiaqi Tian, Zhengpu Han, Dandan Song, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7923-7940
Open Access | Times Cited: 48
Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases
Zaijun Zou, Li Han, Gang Xu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4751-4778
Open Access | Times Cited: 42
Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications
Chunhao Yang, Yunxin Xue, Yu Duan, et al.
Journal of Controlled Release (2024) Vol. 365, pp. 1089-1123
Closed Access | Times Cited: 40
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 22
Physical modulation of mesenchymal stem cell exosomes: A new perspective for regenerative medicine
Dan Wu, Xiansheng Zhao, Jiaheng Xie, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 15
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong, Dongjie Li, Hongbo Meng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3650-3666
Open Access | Times Cited: 66
Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy
Wu Manling, Min Wang, Haoyuan Jia, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2513-2538
Open Access | Times Cited: 48
New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials
Haoer Jin, Sha Qin, Jiang He, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2775-2794
Open Access | Times Cited: 44
Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
Dino Bekric, Matthias Ocker, Christian Mayr, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1826-1826
Open Access | Times Cited: 41
Multiplexed strategies toward clinical translation of extracellular vesicles
Junying Song, Baoqiang Song, Lijun Yuan, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6740-6761
Open Access | Times Cited: 40
Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: novel insights and perspectives
Haiying Wang, Qiao Chu, Qiutong Guan, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 100829-100829
Open Access | Times Cited: 37
Research Advances of Engineered Exosomes as Drug Delivery Carrier
Lianghui Huang, Enguang Wu, Jiawei Liao, et al.
ACS Omega (2023) Vol. 8, Iss. 46, pp. 43374-43387
Open Access | Times Cited: 33
Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma
Ruoning Wang, Xue Wang, Huacong Zhao, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 331-347
Closed Access | Times Cited: 23
Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy
Yi-Chi Yang, Qian Jiang, Ke-Ping Yang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
A comprehensive review of engineered exosomes from the preparation strategy to therapeutic applications
Xiying Fan, Yiwen Zhang, Wenshuai Liu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3500-3521
Closed Access | Times Cited: 11
Extracellular Vesicles in Therapeutics: A Comprehensive Review on Applications, Challenges, and Clinical Progress
Jiyoung Goo, Yeji Lee, Jeongmin Lee, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 311-311
Open Access | Times Cited: 9
Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery
Véréna Poinsot, Nathalie Pizzinat, Varravaddheay Ong‐Meang
Nanomaterials (2024) Vol. 14, Iss. 7, pp. 639-639
Open Access | Times Cited: 9
Engineering Exosomes and Exosome-like Nanovesicles for Improving Tissue Targeting and Retention
Lanya Li, Fei Wang, Dashuai Zhu, et al.
Fundamental Research (2024)
Open Access | Times Cited: 9
Gastric cancer secreted miR-214-3p inhibits the anti-angiogenesis effect of apatinib by suppressing ferroptosis in vascular endothelial cells
W. Wang, Tongtong Wang, YAN ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 489-502
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top